Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2123869 | European Journal of Cancer | 2010 | 8 Pages |
Abstract
Caution should be exercised when interpreting results from historical cross-trial comparisons even if the adjustment of baseline prognostic characteristics can be performed. Cross-trial comparisons have some role in hypothesis-generating, identifying and prioritising promising treatments for further investigation; however RCTs are still essential to guide sound clinical practice.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
C.K. Lee, S.J. Lord, M.R. Stockler, A.S. Coates, V. Gebski, R.J. Simes,